Combination anti-HIV antibody infusions suppress virus for prolonged period

A study published in Nature suggest that the combination of anti-HIV antibodies could offer an alternative to antiretroviral therapy, also named ART, for people that are HIV positive.

"The study authors conclude that the combination bNAb therapy can be highly effective in suppressing HIV in the absence of ART for extended periods, provided that antibody-resistant virus is not present at the time individuals begin antibody treatment. Larger studies are needed to confirm the findings, but as next-generation bNAbs with increased potency and durability become available".

MC Sneller et al. Combination anti-HIV antibodies provide sustained virologic suppression. Nature DOI: 10.1038/s41586-022-04797-9 

This study was reported by the NIH: Combination anti-HIV antibody infusions suppress virus for prolonged period | National Institutes of Health (NIH)